OncLive.comΒ· @OncLive Β· XΒ·Β· 16 hours agoScore70
Body
π Significant PFS improvements were shown with iza-bren vs chemotherapy in pretreated HR+/HER2β advanced breast cancer, according to new data from the phase 3 PANKU-Breast01 trial
Read more here β‘οΈ: https://www.onclive.com/view/panku-breast01-iza-bren-improves-pfs-vs-chemotherapy-pretreated-hr-her2-advanced-breast-cancer
#bcsm #oncology #ESMO26 @myESMO
107 views Β· 0 likes Β· 0 reposts Β· 0 replies
Conference abstracts
LBA50matched by Proffered paper 1: Breast cancer, early and advanced stage
PANKU-Breast01: Randomized phase III study of izalontamab brengitecan (iza-bren) in previously treated unresectable locally advanced or metastatic (LA/M) hormone receptor-positive/HER2-negative (HR+/HER2-) breast cancer (BC)
https://esmocongress.esmo.orgSource: OncLive.com Β· x.com